Key summary of German national treatment guidance for hospitalized COVID-19 patients: Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

PURPOSE: This executive summary of a national living guideline aims to provide rapid evidence based recommendations on the role of drug interventions in the treatment of hospitalized patients with COVID-19. METHODS: The guideline makes use of a systematic assessment and decision process using an evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Malin, Jakob J., Spinner, Christoph D., Janssens, Uwe, Welte, Tobias, Weber-Carstens, Steffen, Schälte, Gereon, Gastmeier, Petra, Langer, Florian, Wepler, Martin, Westhoff, Michael, Pfeifer, Michael, Rabe, Klaus F., Hoffmann, Florian, Böttiger, Bernd W., Weinmann-Menke, Julia, Kersten, Alexander, Berlit, Peter, Krawczyk, Marcin, Nehls, Wiebke, Fichtner, Falk, Laudi, Sven, Stegemann, Miriam, Skoetz, Nicole, Nothacker, Monika, Marx, Gernot, Karagiannidis, Christian, Kluge, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259552/
https://www.ncbi.nlm.nih.gov/pubmed/34228347
http://dx.doi.org/10.1007/s15010-021-01645-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259552/
https://www.ncbi.nlm.nih.gov/pubmed/34228347
http://dx.doi.org/10.1007/s15010-021-01645-2

Ejemplares similares